Research-Only Peptides: Status, Evidence, and Risks
These peptides are NOT approved for human use
Research-only peptides have not been evaluated by the FDA for safety, efficacy, or quality in humans. They are not legal to market or sell for human consumption. Self-administration of these substances carries significant health and legal risks.
FDA Safety-Risk List for Compounding
The FDA maintains a list of substances that may present significant safety risks when used in compounding. Several popular research-only peptides, including BPC-157 and thymosin beta-4 fragment (TB-500), appear on this list. Inclusion means the FDA has identified specific concerns about characterization, purity, or safety data that make these substances unsuitable for compounding into drug products.
Compounding pharmacies are generally prohibited from using substances on this list, and patients should exercise extreme caution with any product containing these ingredients.
Why “Research Use Only” Labeling Does Not Protect Consumers
Many online vendors sell peptides labeled as “for research use only” or “not for human consumption.” This labeling is often used as a regulatory workaround. It does not confer any legal protection on the buyer and does not guarantee product quality, purity, or accurate labeling of contents or concentration.
Consumers who purchase and self-administer these products are taking unverified substances with unknown purity, unknown concentrations, and no clinical oversight. The FDA has warned that products sold under these labels may be contaminated, mislabeled, or contain entirely different substances than advertised.
IND Requirements for Investigational Drugs
For a peptide to be legally administered to humans for therapeutic or investigational purposes, it must either be FDA-approved or administered under an Investigational New Drug (IND) application. The IND process requires submission of preclinical safety data, manufacturing quality information, and a clinical protocol to the FDA before human testing can begin.
Using a research-only peptide outside of an IND-approved clinical trial means there is no regulatory oversight, no adverse event monitoring system, and no assurance that the product meets pharmaceutical standards. Clinicians who administer unapproved peptides outside of the IND framework may face regulatory and legal consequences.
Research-Only Peptides in Our Directory
18 peptides that are not approved for human use.
Widely discussed for tissue repair and gut healing, but NOT FDA-approved. Human evidence is extremely limited despite popular claims.
Early ResearchBPC-157
Learn more →
Promoted for wound healing and recovery, but NOT FDA-approved and on the FDA safety-risk list. Robust human evidence is lacking.
Early ResearchTB-500
Learn more →
Explored for stimulating growth hormone release, which may affect body composition and skin health. NOT FDA-approved with significant data gaps.
Early ResearchCJC-1295
Learn more →
One of the most studied peptides for skin and hair. Naturally occurs in your body but declines with age. Shown to boost collagen, improve skin elasticity, and may support hair thickness.
Early ResearchGHK-Cu
Learn more →
Popular in wellness clinics for its potential to support lean muscle, better sleep, and recovery. Often paired with CJC-1295. Not FDA-approved — talk to your doctor.
Early ResearchIpamorelin
Learn more →
A cutting-edge mitochondrial peptide being studied for energy metabolism and cellular health. Early research is promising but it is still very new — no FDA approval yet.
Early ResearchMOTS-c
Learn more →
A fragment of growth hormone that may help with fat metabolism without the side effects of full growth hormone. Popular in wellness clinics but still lacks strong human evidence.
Early ResearchAOD-9604
Learn more →
Marketed online for tanning without sun exposure, but carries serious safety risks including potential links to skin cancer. We strongly recommend discussing safer alternatives with a dermatologist.
Early ResearchMelanotan II
Learn more →
A longevity peptide being studied for its potential effects on telomeres and cellular aging. Interesting early research but far from proven — approach with healthy skepticism.
Early ResearchEpithalon
Learn more →
A mitochondrial peptide that targets the inner mitochondrial membrane to improve cellular energy production. Has been in serious clinical trials unlike many research peptides — but still not FDA-approved.
Early ResearchSS-31 (Elamipretide)
Learn more →
Used for anxiety, brain fog, and focus. Acts on both GABA (calming) and NMDA (memory) pathways. One of the few peptides with a pharmaceutical approval history, though not in the US.
Early ResearchSelank
Learn more →
A powerful anti-inflammatory tripeptide that shows promise for gut inflammation and skin conditions. Often used in combination with BPC-157 for gut healing protocols. Still early-stage research.
Early ResearchKPV
Learn more →
One of the most established immune-modulating peptides worldwide — approved in 30+ countries, just not in the US. Supports immune system balance rather than just boosting it. Now available through US compounding pharmacies.
Early ResearchThymosin Alpha-1
Zadaxin
Learn more →
A naturally occurring neuropeptide that connects your gut and brain. Being explored for gut healing, circadian rhythm regulation, and jet lag recovery. Early research but growing interest in the wellness community.
Early ResearchVIP
Learn more →
The most talked-about senolytic peptide — designed to selectively eliminate senescent ("zombie") cells that accumulate with age. Exciting concept but very early-stage research with limited human data.
Early ResearchFOXO4-DRI
Learn more →
The leading peptide candidate for "leaky gut" — it works by tightening the junctions between gut cells. Currently in Phase 3 clinical trials for celiac disease, which is further along than most peptides on this list.
Early ResearchLarazotide
Learn more →
A peptide that acts on the innate repair receptor — it helps your body reduce inflammation and repair tissue without suppressing your immune system. Being studied for neuropathy, gut health, and metabolic regulation.
Early ResearchARA290
Learn more →
A thymus extract peptide used in Russian medicine for immune restoration and anti-aging. Part of the "bioregulator" family of peptides developed by the Khavinson group. Limited Western clinical data but a long history of use in Russia.
Early ResearchThymalin
Learn more →
Curious about what IS approved?
Check out FDA-approved peptides that address similar goals — with established safety profiles and real clinical evidence.
See Approved Options